Cabergoline
Product Images NDC 83085-003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 83085-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Skg Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Image001)

This text provides valuable information about Cabergoline tablets, each containing 0.5 mg of Cabergoline. The tablets are distributed by SKG Pharma Inc. and are manufactured in India. The storage instructions suggest keeping the tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The text also emphasizes the need to store the medication in its original container and to keep it out of reach of children. The packaging includes details such as batch information, variable data, a unique serial number printed on each label, and the 2D data matrix.*

FDA Label Image

Structutre (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.